📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-11 18:03
359 analysed today
FollowTelegram
359
Today
150,798
All-time analysed
43,187
Positive
6,705
Negative
92,133
Neutral
8,705
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
4 announcements match the current filters (relevance ≥ 5).
28% PAT Growth: Prevest Denpro Reports Strong Q1 FY27 Results, Declares ₹1 Dividend
Prevest Denpro reported a 20.94% YoY increase in consolidated revenue to ₹19.07 Cr for Q1 FY27, while consolidated PAT grew 27.99% to ₹5.64 Cr. The company maintained strong operational efficiency with EBITDA growing 24.73% YoY to ₹8.08 Cr, outpacing revenue growth. A dividend of ₹1 per share (10%) was recommended for FY 2025-26. The results show steady growth compared to the previous quarter, with consolidated revenue up 0.67% QoQ, continuing the momentum from FY26.
Confidence: HIGH
What changedThe company reported its first-quarter results for FY27, showing double-digit growth in both top and bottom lines compared to the same period last year.
Why it mattersSustained growth in the niche dental supplies segment validates the company's R&D-led strategy and ability to maintain high margins, with EBITDA growth exceeding revenue growth.
Consolidated Revenue (Q1): ₹19.07 CrConsolidated PAT (Q1): ₹5.64 CrYoY Revenue Growth: 20.94%YoY PAT Growth: 27.99%Dividend per share: ₹1Q1 Revenue vs TTM Revenue: ~26.5%
📅 Short termPositive sentiment is expected due to strong YoY growth and the dividend declaration, which may support the stock price after a period of decline.
📈 Long termStructural growth remains intact as the company targets ₹100 Cr revenue and expands into high-margin segments like 3D printing resins and digital dentistry.
⚠ Risk flags
- Forex fluctuations affecting export revenues
- Inventory build-up risks
- Domestic market slowdowns
Key Highlights
Consolidated Revenue from Operations grew 20.94% YoY to ₹1,906.83 lakh
Consolidated PAT increased 27.99% YoY to ₹563.86 lakh
EBITDA grew 24.73% YoY to ₹808.14 lakh, indicating margin expansion
Recommended a dividend of 10%, equivalent to ₹1 per equity share
Standalone revenue grew 23.66% YoY to ₹1,944.33 lakh
👀 What to Watch
Monitor the company's progress toward its target of ₹100 Cr revenue within 3 years and the scaling of its 'Prevest Direct' e-commerce platform. Watch for the impact of international expansion on margins in upcoming quarters.
Prevest Denpro Sets September 05, 2026, as Record Date for FY26 Final Dividend
Prevest Denpro has fixed September 05, 2026, as the record date to determine shareholder eligibility for the final dividend of FY 2025-26. The dividend payout is subject to approval at the upcoming 27th Annual General Meeting. This follows a strong financial year where the company reported a PAT of ₹21 Cr on a revenue of ₹72 Cr, maintaining a robust operating margin of 36%. As a debt-free company with a 25% ROCE, this move continues its trend of returning capital to shareholders.
Confidence: HIGH
What changedThe company has officially scheduled the record date for its final dividend distribution for the 2025-26 financial year.
Why it mattersIt confirms the timeline for profit distribution to shareholders, reflecting the company's ability to generate surplus cash from its 36% operating margins and debt-free status.
Record Date: September 05, 2026FY26 Net Profit: ₹21.0 CrFY26 Revenue: ₹72.0 CrOperating Profit Margin (FY26): 36.0%Dividend Amount: not disclosed
📅 Short termThe stock may experience routine price adjustments around the ex-dividend date (typically one business day prior to the record date).
📈 Long termLimited structural impact; the dividend is a routine distribution of earnings consistent with the company's high-margin medical equipment business model.
Key Highlights
Record date for final dividend eligibility fixed for September 05, 2026.
Dividend pertains to the full financial year ending March 31, 2026 (FY 2025-26).
Payment is contingent upon approval at the company's 27th Annual General Meeting.
Company reported FY26 revenue of ₹72.0 Cr, a 14.3% increase over FY25's ₹63.0 Cr.
Net profit for FY26 stood at ₹21.0 Cr with an EPS of ₹17.85.
👀 What to Watch
Investors should monitor the upcoming AGM notice for the specific dividend amount per share. To be eligible for the payout, shares must be held in the demat account by the record date of September 05, 2026.
28% YoY Profit Growth in Q1 FY27; Rs 1.00 Dividend Recommended
Prevest Denpro reported a strong start to FY27 with consolidated revenue growing 20.9% YoY to Rs 19.07 Cr. Consolidated net profit increased 27.9% YoY to Rs 5.64 Cr, maintaining a healthy net margin of 29.5%. The Board recommended a final dividend of Rs 1.00 per share for FY26. Results were slightly impacted by a Rs 27.80 lakh increase in employee costs following the implementation of new Labour Codes.
Confidence: HIGH
What changedThe company has transitioned to the new Indian Labour Codes and reported its first quarter of FY27 with sustained double-digit YoY growth.
Why it mattersThe results confirm the company's ability to maintain high margins (PAT ~30%) while absorbing regulatory cost increases, keeping it on track for its long-term revenue targets.
Consolidated Revenue (Q1 FY27): Rs 19.07 CrConsolidated PAT (Q1 FY27): Rs 5.64 CrYoY Revenue Growth: 20.9%Dividend per Share: Rs 1.00Labour Code Cost Impact: Rs 27.80 lakhQ1 Revenue vs TTM Revenue: 26.5%
📅 Short termThe stock may see positive sentiment driven by the 28% YoY profit growth and the dividend announcement.
📈 Long termThe company continues to demonstrate high operational efficiency (ROCE 25%) and is scaling towards its Rs 100 Cr revenue target through international expansion.
⚠ Risk flags
- Loss-making foreign subsidiaries
- Increased employee benefit obligations due to new Labour Codes
Key Highlights
Consolidated revenue from operations rose to Rs 19.07 Cr, up 20.9% from Rs 15.77 Cr in Q1 FY26.
Consolidated Net Profit reached Rs 5.64 Cr compared to Rs 4.41 Cr in the same quarter last year.
Recommended a final dividend of 10% (Rs 1.00 per equity share) for FY 2025-26.
Employee benefit expenses increased by Rs 27.80 lakh due to the implementation of new Labour Codes effective April 1, 2026.
Foreign subsidiaries (Axiodent Inc. and Prevest Denpro Gulf) reported a combined net loss of Rs 16.81 Lakhs.
👀 What to Watch
Monitor the stabilization of employee costs under the new Labour Codes and the revenue ramp-up in the newly formed international subsidiaries to see if they turn profitable.
28% YoY PAT Growth in Q1 FY27; Rs 1.00 Final Dividend Recommended
Prevest Denpro reported a strong start to FY27 with consolidated revenue rising 20.9% YoY to Rs 19.07 Cr. Consolidated Net Profit grew 27.9% YoY to Rs 5.64 Cr, significantly outpacing the company's long-term 15% CAGR target. The board recommended a final dividend of Rs 1.00 per share (10% of face value) for FY26. Profitability remained robust with a PBT margin of 39.6%, even after absorbing a Rs 27.80 lakh increase in employee costs due to new Labour Code implementations.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results and recommended a final dividend for the previous financial year.
Why it mattersThe results demonstrate the company's ability to maintain high margins (39%+) and double-digit growth in the niche dental materials segment, despite regulatory cost headwinds.
Consolidated Revenue (Q1 FY27): Rs 19.07 CrConsolidated PAT (Q1 FY27): Rs 5.64 CrYoY PAT Growth: 27.99%Final Dividend: Rs 1.00 per shareLabour Code Cost Impact: Rs 27.80 lakhRevenue vs TTM Revenue: ~26.5%
📅 Short termThe stock may see positive momentum due to the earnings beat relative to the 15% growth guidance and the dividend announcement.
📈 Long termThe structural shift toward digital dentistry and 3D printing resins remains a key long-term driver for reaching the Rs 100 Cr revenue milestone.
⚠ Risk flags
- Loss-making international subsidiaries
- Increased employee benefit obligations under new Labour Codes
Key Highlights
Consolidated Revenue from operations increased 20.9% YoY to Rs 19.07 Cr from Rs 15.77 Cr.
Consolidated Net Profit rose 27.9% YoY to Rs 5.64 Cr compared to Rs 4.41 Cr in Q1 FY26.
Recommended a final dividend of Rs 1.00 per equity share (10% of face value) for FY26.
Employee benefit expenses increased by Rs 27.80 lakh due to the implementation of new Labour Codes effective April 1, 2026.
Foreign subsidiaries Axiodent Inc. and Prevest Denpro Gulf reported a combined net loss of Rs 16.81 Lakhs on revenue of Rs 5.71 Lakhs.
👀 What to Watch
Monitor the scaling of international subsidiaries and the 'Prevest Direct' e-commerce platform to see if they can turn profitable and contribute to the Rs 100 Cr revenue target.
